Maire A Duggan

Summary

Affiliation: University of Calgary
Country: Canada

Publications

  1. ncbi request reprint The accuracy and interobserver reproducibility of endometrial dating
    M A Duggan
    Department of Pathology and Laboratory Medicine, University of Calgary, Alberta, Canada
    Pathology 33:292-7. 2001
  2. ncbi request reprint A review of the natural history of cervical intraepithelial neoplasia
    Maire A Duggan
    Department of Pathology and Laboratory Medicine, University of Calgary, Division of Cytopathology, Calgary Laboratory Services, Calgary, Alberta, Canada
    Gan To Kagaku Ryoho 29:176-93. 2002
  3. ncbi request reprint ERCP-directed brush cytology prepared by the Thinprep method: test performance and morphology of 149 cases
    M A Duggan
    Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
    Cytopathology 15:80-6. 2004
  4. ncbi request reprint Comparative study of the ThinPrep Pap test and conventional cytology results in a Canadian cohort
    M A Duggan
    Department of Pathology and Laboratory Medicine, University of Calgary, AB, Canada
    Cytopathology 17:73-81. 2006
  5. ncbi request reprint Atypical immature cervical metaplasia: immunoprofiling and longitudinal outcome
    Maire A Duggan
    Division of Anatomic Pathology and Cytopathology, Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
    Hum Pathol 37:1473-81. 2006
  6. doi request reprint PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma
    John B McIntyre
    Department of Oncology, University of Calgary, Calgary, Alberta, Canada Translational Laboratory, Tom Baker Cancer Center, Calgary, Alberta, Canada
    Gynecol Oncol 132:188-93. 2014
  7. ncbi request reprint Controversy in colposcopic management: a Canadian survey
    Gregory S Nelson
    Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Calgary, Calgary, Alberta
    J Obstet Gynaecol Can 28:36-40. 2006
  8. doi request reprint MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome
    Gregg S Nelson
    Department of Gynecologic Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada University of Calgary, Calgary, Alberta, Canada Electronic address
    Gynecol Oncol 131:309-14. 2013
  9. pmc Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium
    Martin Köbel
    Authors Affiliations Department of Pathology and Laboratory Medicine Department of Population Health Research, Alberta Health Services Cancer Care and Department of Medical Genetics, University of Calgary, Calgary, Alberta Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada Department of Medical Oncology Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology Division of Biomedical Statistics and Informatics, Department of Health Science Research Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas University of Texas School of Public Health, Houston, Texas Roswell Park Cancer Institute, Buffalo, New York, New York Women s Cancer Research Center, Magee Womens Research Institute, University of Pittsburgh Cancer Institute Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania Gynaecological Cancer Research Centre, Women s Cancer, UCL EGA Institute for Women s Health Department of Pathology, Cancer Institute, UCL, London, United Kingdom and Department of Preventive Medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California
    Cancer Epidemiol Biomarkers Prev 22:1677-86. 2013
  10. ncbi request reprint POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium
    Bo Meng
    Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada
    Gynecol Oncol 134:15-9. 2014

Collaborators

Detail Information

Publications17

  1. ncbi request reprint The accuracy and interobserver reproducibility of endometrial dating
    M A Duggan
    Department of Pathology and Laboratory Medicine, University of Calgary, Alberta, Canada
    Pathology 33:292-7. 2001
    ..Accuracy and interobserver reproducibility were unaffected by refresher training, suggesting the limits of histological dating have been reached...
  2. ncbi request reprint A review of the natural history of cervical intraepithelial neoplasia
    Maire A Duggan
    Department of Pathology and Laboratory Medicine, University of Calgary, Division of Cytopathology, Calgary Laboratory Services, Calgary, Alberta, Canada
    Gan To Kagaku Ryoho 29:176-93. 2002
    ..Possible biomarkers include aneuploidy, aneusomy of chromosomes 1 and 3, Ras and bcl-2 oncogene over expression, and cytokeratin 13 protein under-expression...
  3. ncbi request reprint ERCP-directed brush cytology prepared by the Thinprep method: test performance and morphology of 149 cases
    M A Duggan
    Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
    Cytopathology 15:80-6. 2004
    ..The performance of Thinprep-prepared brushings from this anatomical site was comparable with conventional preparations...
  4. ncbi request reprint Comparative study of the ThinPrep Pap test and conventional cytology results in a Canadian cohort
    M A Duggan
    Department of Pathology and Laboratory Medicine, University of Calgary, AB, Canada
    Cytopathology 17:73-81. 2006
    ..To follow-up all test results for a minimum of 2 years and assess performance based on this outcome...
  5. ncbi request reprint Atypical immature cervical metaplasia: immunoprofiling and longitudinal outcome
    Maire A Duggan
    Division of Anatomic Pathology and Cytopathology, Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
    Hum Pathol 37:1473-81. 2006
    ..The similarity between AIM and LSIL in regard to their immunoprofile as well as outcome suggests AIM is a morphological type of LSIL...
  6. doi request reprint PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma
    John B McIntyre
    Department of Oncology, University of Calgary, Calgary, Alberta, Canada Translational Laboratory, Tom Baker Cancer Center, Calgary, Alberta, Canada
    Gynecol Oncol 132:188-93. 2014
    ..To evaluate the outcome association of PIK3CA mutational status within histological types of rigorously classified high-grade endometrial carcinomas...
  7. ncbi request reprint Controversy in colposcopic management: a Canadian survey
    Gregory S Nelson
    Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Calgary, Calgary, Alberta
    J Obstet Gynaecol Can 28:36-40. 2006
    ..Our goal was to document the colposcopic management of the latter group in Canada...
  8. doi request reprint MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome
    Gregg S Nelson
    Department of Gynecologic Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada University of Calgary, Calgary, Alberta, Canada Electronic address
    Gynecol Oncol 131:309-14. 2013
    ..To assess the prevalence of MMR deficiency (dMMR) in contemporary reclassified high-grade endometrial carcinomas and correlate dMMR with molecular alterations and patient outcome...
  9. pmc Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium
    Martin Köbel
    Authors Affiliations Department of Pathology and Laboratory Medicine Department of Population Health Research, Alberta Health Services Cancer Care and Department of Medical Genetics, University of Calgary, Calgary, Alberta Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada Department of Medical Oncology Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology Division of Biomedical Statistics and Informatics, Department of Health Science Research Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas University of Texas School of Public Health, Houston, Texas Roswell Park Cancer Institute, Buffalo, New York, New York Women s Cancer Research Center, Magee Womens Research Institute, University of Pittsburgh Cancer Institute Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania Gynaecological Cancer Research Centre, Women s Cancer, UCL EGA Institute for Women s Health Department of Pathology, Cancer Institute, UCL, London, United Kingdom and Department of Preventive Medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California
    Cancer Epidemiol Biomarkers Prev 22:1677-86. 2013
    ..Our aim was to evaluate histologic type assessments across the centers participating in the Ovarian Tumor Tissue Analysis (OTTA) consortium using an immunohistochemical (IHC) prediction model...
  10. ncbi request reprint POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium
    Bo Meng
    Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada
    Gynecol Oncol 134:15-9. 2014
    ..The aim of this study is to further characterize the clinical and pathologic significance of POLE exonuclease domain mutations in high-grade endometrial carcinomas...
  11. doi request reprint An audit of the cervical cancer screening histories of 246 women with carcinoma
    Maire A Duggan
    Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
    J Low Genit Tract Dis 16:263-70. 2012
    ..Women with cervical carcinoma and residing in the Calgary Health Region between 1996 and 2001 were audited to characterize factors in the opportunistic cervical cancer screening pathway contributing to screening failures...
  12. ncbi request reprint Primary squamous cell carcinoma of the endometrium: clinicopathologic and molecular characteristics
    Nicole Bures
    Departments of Pathology and Laboratory Medicine N B, D D, M A D Obstetrics and Gynecology G N, M A D, Faculty of Medicine, University of Calgary Research and Analytics, Alberta Health Services Q D, Calgary, Alberta, Canada Department of Pathology, Lee Moffitt Cancer Center, Tampa, Florida A M
    Int J Gynecol Pathol 32:566-75. 2013
    ..PSCCE has molecular alterations involving the pRB-Cyclin D1-CDK4/6-p16 pathway, and pTEN. In contrast to the type I EACC, PSCCE is not hormonally sensitive, suggesting a unique pathogenesis. ..
  13. ncbi request reprint Primary carcinoma of the rectovaginal septum diagnosed as uterine prolapse
    Gregory S Nelson
    Department of Obstetrics and Gynecology, Foothills Medical Centre, Calgary, AB
    J Obstet Gynaecol Can 27:1027-30. 2005
    ..Primary carcinoma of the rectovaginal septum is very rare. Most cases are associated with documented endometriosis, and patients will often present with vaginal or rectal bleeding...
  14. ncbi request reprint Precursor lesions and prognostic factors in primary peritoneal serous carcinoma
    Sandra Lee
    Departments of Pathology and Laboratory Medicine S L, M A D Obstetrics and Gynecology G N, M A D Oncology G N, University of Calgary Clinical Research Unit Q D, Tom Baker Cancer Centre, Calgary, AB, Canada Department of Pathology, Lee Moffit Cancer Center, Tampa, Florida A M M
    Int J Gynecol Pathol 32:547-55. 2013
    ..Tumor grade was the only significant prognostic factor. ..
  15. ncbi request reprint Multinucleated giant cells in a breast fine needle aspirate
    Clinton Ho
    Department of Pathology and Laboratory Medicine, University of Calgary, Alberta, Canada
    Cytopathology 13:247-53. 2002
  16. doi request reprint Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study
    Martin Köbel
    Department of Pathology and Laboratory Medicine, University of Calgary, Canada
    Am J Surg Pathol 34:984-93. 2010
    ..This has implications for clinical trials of subtype-specific ovarian carcinoma treatments...
  17. pmc Case-control study of lifetime total physical activity and endometrial cancer risk
    Christine M Friedenreich
    Alberta Health Services, 1331 29 St NW, Calgary, AB T2N 4N2, Canada
    Cancer Causes Control 21:1105-16. 2010
    ..This study provides evidence for a decreased risk between lifetime physical activity and endometrial cancer risk and a possible increased risk associated with sedentary behavior...